Sabrina Z Van Ginkel

Title: Innovations by Sabrina Z Van Ginkel

Introduction

Sabrina Z Van Ginkel is a notable inventor based in Homewood, AL (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapies for mycobacterial infections. With a total of 2 patents, her work is paving the way for innovative medical solutions.

Latest Patents

Sabrina's latest patents focus on the Mycobacterium fol A gene that encodes for the enzyme dihydrofolate reductase (DHFR). The inventions relate to the nucleic acid sequence and amino acid sequence of DHFR from mycobacteria, as well as the expression of recombinant DHFR protein. Utilizing this recombinant protein, novel therapies and diagnostic strategies can be developed. Selective antimycobacterial compositions can be designed to treat mycobacterial infections in patients. The inventions include novel recombinant nucleic acids encoding DHFR for mycobacteria, as well as recombinant DHFR peptides produced by such sequences. Additionally, they encompass vaccines, diagnostic kits, cells, and therapies utilizing these peptides and nucleic acid sequences. The present inventions also relate to methods for using these sequences to develop drugs specific to mycobacteria and to identify corresponding sequences in other species.

Career Highlights

Sabrina is currently associated with Southern Research Institute, where she continues to advance her research and innovations. Her work is instrumental in the development of new therapeutic approaches in the field of infectious diseases.

Collaborations

Some of her notable coworkers include William W Barrow and Thomas P Dooley, who contribute to her research endeavors and collaborative projects.

Conclusion

Sabrina Z Van Ginkel's innovative work in biotechnology and her patents on mycobacterial treatments highlight her significant role in advancing medical science. Her contributions are essential for developing effective therapies for challenging infections.